First reported use of elvitegravir and cobicistat during pregnancy

AIDS. 2016 Mar 13;30(5):807-8. doi: 10.1097/QAD.0000000000000976.

Authors

Stein Schalkwijk¹, Angela Colbers, Deborah Konopnicki, Rick Greupink, Frans G M Russel, David Burger; PANNA network

Affiliation

¹ aDepartment of Pharmacy bDepartment of Pharmacology and Toxicology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands cInfectious Diseases Department, Saint-Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium.

PMID: 26913711
DOI: 10.1097/QAD.0000000000000976

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Anti-HIV Agents / pharmacokinetics
Anti-HIV Agents / therapeutic use*
Cobicistat / pharmacokinetics
Cobicistat / therapeutic use*
Female
HIV Infections / drug therapy*
Humans
Plasma / chemistry
Pregnancy
Pregnancy Complications, Infectious / drug therapy*
Quinolones / pharmacokinetics
Quinolones / therapeutic use*

Substances

Anti-HIV Agents
Quinolones
elvitegravir
Cobicistat